Mancini, G.B. John

Optimal Medical Therapy with or without PCI for Stable Coronary Disease

Boden, W. E., O'Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., Knudtson, M., Dada, M., Casperson, P., Harris, C. L., et al. (2007) · New England Journal of Medicine

Coronary Interventions and DiagnosticsAntiplatelet Therapy and Cardiovascular Diseases

Cited by 4,699

2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult

Anderson, T. J., Grégoire, J., Pearson, G. J., Barry, A. R., Couture, P., Dawes, M., Francis, G. A., Genest, J., Grover, S., Gupta, M., et al. (2016) · Canadian Journal of Cardiology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 1,173

Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance

Laufs, U., Banach, M., Mancini, G. B. J., Gaudet, D., Bloedon, L. T., Sterling, L. R., Kelly, S., & Stroes, E. S. G. (2019) · Journal of the American Heart Association

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 432

Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study

Ballantyne, C. M., Banach, M., Mancini, G. B. J., Lepor, N. E., Hanselman, J. C., Zhao, X., & Leiter, L. A. (2018) · Atherosclerosis

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 422

The Role of Nutraceuticals in Statin Intolerant Patients

Banach, M., Patti, A. M., Giglio, R. V., Cicero, A. F. G., Atanasov, A. G., Bajraktari, G., Bruckert, E., Descamps, O., Djuric, D. M., Ezhov, M., et al. (2018) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthNatural Products and Biological Research

Cited by 272

Optimizing cholesterol treatment in patients with muscle complaints

Rosenson, R. S., Baker, S., Banach, M., Borow, K. M., Braun, L. T., Bruckert, E., Brunham, L. R., Catapano, A. L., Elam, M. B., Mancini, G. B. J., et al. (2017) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthCancer, Lipids, and Metabolism

Cited by 193

Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update

Mancini, G. B. J., Tashakkor, A. Y., Baker, S., Bergeron, J., Fitchett, D., Frohlich, J., Genest, J., Gupta, M., Hegele, R. A., Ng, D. S., et al. (2013) · Canadian Journal of Cardiology

Lipoproteins and Cardiovascular HealthCancer, Lipids, and Metabolism

Cited by 173

Introducing the ‘Drucebo’ effect in statin therapy: a systematic review of studies comparing reported rates of statin‐associated muscle symptoms, under blinded and open‐label conditions

Penson, P. E., Mancini, G. B. J., Toth, P. P., Martin, S. S., Watts, G. F., Sahebkar, A., Mikhailidis, D. P., Banach, M., & on behalf of Lipid and Blood Pressure Meta‐Analysis Collaboration (LBPMC) Group & International Lipid Expert Panel (ILEP) (2018) · Journal of Cachexia, Sarcopenia and Muscle

Pain Management and Placebo EffectLipoproteins and Cardiovascular Health

Cited by 110

Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials

Bays, H. E., Banach, M., Catapano, A. L., Duell, P. B., Gotto, A. M., Laufs, U., Leiter, L. A., Mancini, G. B. J., Ray, K. K., Bloedon, L. T., et al. (2020) · Journal of Clinical Lipidology

Lipoproteins and Cardiovascular HealthPharmacovigilance and Adverse Drug Reactions

Cited by 103

Dyslipidemia

Mancini, G. B. J., Hegele, R. A., & Leiter, L. A. (2018) · Canadian Journal of Diabetes

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 70

Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease

Mancini, G. B. J., Farkouh, M. E., Brooks, M. M., Chaitman, B. R., Boden, W. E., Vlachos, H., Hartigan, P. M., Siami, F. S., Sidhu, M. S., Bittner, V., et al. (2016) · Journal of the American College of Cardiology

Coronary Interventions and DiagnosticsCardiac Imaging and Diagnostics

Cited by 64

Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes

Farkouh, M. E., Sidhu, M. S., Brooks, M. M., Vlachos, H., Boden, W. E., Frye, R. L., Hartigan, P., Siami, F. S., Bittner, V. A., Chaitman, B. R., et al. (2019) · Journal of the American College of Cardiology

Coronary Interventions and DiagnosticsChronic Kidney Disease and Diabetes

Cited by 58

Lifestyle, glycosylated hemoglobin A1c, and survival among patients with stable ischemic heart disease and diabetes

Mancini, G. B. J., Maron, D. J., Hartigan, P. M., Spertus, J. A., Kostuk, W. J., Berman, D. S., Teo, K. K., Weintraub, W. S., & Boden, W. E. (2019) · Journal of the American College of Cardiology

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 33

Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials

Mancini, G. B. J., Boden, W. E., Brooks, M. M., Vlachos, H., Chaitman, B. R., Frye, R., Bittner, V., Hartigan, P. M., & Dagenais, G. R. (2018) · Atherosclerosis

Coronary Interventions and DiagnosticsCardiac Imaging and Diagnostics

Cited by 15

Does management of lipid lowering differ between specialists and primary care: Insights from GOAL Canada

Langer, A., Tan, M., Goodman, S. G., Grégoire, J., Lin, P. J., Mancini, G. B. J., Stone, J. A., & Leiter, L. A. (2021) · International Journal of Clinical Practice

Lipoproteins and Cardiovascular HealthClinical practice guidelines implementation

Cited by 6